<![CDATA[QPS Holdings, LLC 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=44585>Wed, 29 Apr 2026 18:38:39 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials]]>https://www.newswire.co.kr/newsRead.php?no=1027081Fri, 16 Jan 2026 11:20:00 +0900<![CDATA[QPS, 임상시험 약물감시 강화를 위해 ‘오라클 아거스’ 안전성 데이터베이스 도입]]>https://www.newswire.co.kr/newsRead.php?no=1027082Fri, 16 Jan 2026 11:20:00 +0900<![CDATA[QPS Celebrates 30th Anniversary]]>https://www.newswire.co.kr/newsRead.php?no=1012627Sun, 08 Jun 2025 10:50:00 +0900<![CDATA[QPS, 창립 30주년 기념]]>https://www.newswire.co.kr/newsRead.php?no=1012628Sun, 08 Jun 2025 10:50:00 +0900<![CDATA[QPS India Successfully Completes Week-Long US FDA Regulatory Inspection]]>https://www.newswire.co.kr/newsRead.php?no=1010551Fri, 02 May 2025 15:20:00 +0900<![CDATA[QPS 인디아, 일주일 간의 미국 FDA 규제 검사 성공적으로 완료]]>https://www.newswire.co.kr/newsRead.php?no=1010553Fri, 02 May 2025 15:20:00 +0900<![CDATA[QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis]]>https://www.newswire.co.kr/newsRead.php?no=1009997Thu, 24 Apr 2025 10:30:00 +0900<![CDATA[QPS, MASH·궤양성 대장염·상처 치유·건선 등이 포함된 강력한 약리학 질환 모델로 포트폴리오 확대]]>https://www.newswire.co.kr/newsRead.php?no=1009998Thu, 24 Apr 2025 10:30:00 +0900<![CDATA[QPS Launches New Leukopak and Cell Therapy Products Facility]]>https://www.newswire.co.kr/newsRead.php?no=1000799Thu, 14 Nov 2024 14:00:00 +0900<![CDATA[QPS, 새로운 루코팩 및 세포요법 제품 시설 출시]]>https://www.newswire.co.kr/newsRead.php?no=1000801Thu, 14 Nov 2024 14:00:00 +0900<![CDATA[QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development]]>https://www.newswire.co.kr/newsRead.php?no=992469Fri, 28 Jun 2024 11:30:00 +0900<![CDATA[QPS, 임상실험 및 세포 치료제 개발을 위한 신규 실험실 서비스 발표]]>https://www.newswire.co.kr/newsRead.php?no=992471Fri, 28 Jun 2024 11:30:00 +0900<![CDATA[QPS Announces New Global Clinical Research Operations Leadership]]>https://www.newswire.co.kr/newsRead.php?no=992014Fri, 21 Jun 2024 13:40:00 +0900<![CDATA[QPS, 새로운 글로벌 임상 연구 운영 리더십 발표]]>https://www.newswire.co.kr/newsRead.php?no=992015Fri, 21 Jun 2024 13:40:00 +0900<![CDATA[QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials]]>https://www.newswire.co.kr/newsRead.php?no=990165Wed, 22 May 2024 13:40:00 +0900<![CDATA[QPS, 비만 임상시험의 수요 증가 대응 위해 플로리다주 마이애미 클리닉 확장]]>https://www.newswire.co.kr/newsRead.php?no=990166Wed, 22 May 2024 13:40:00 +0900<![CDATA[QPS Significantly Enhances Mass Spectrometry Laboratory Capacity]]>https://www.newswire.co.kr/newsRead.php?no=982537Fri, 12 Jan 2024 10:20:00 +0900<![CDATA[QPS, 질량 분석 실험실 역량 대폭 강화]]>https://www.newswire.co.kr/newsRead.php?no=982538Fri, 12 Jan 2024 10:20:00 +0900<![CDATA[QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development]]>https://www.newswire.co.kr/newsRead.php?no=981163Fri, 15 Dec 2023 15:20:00 +0900<![CDATA[QPS, UPLC-HRMS의 유럽 확장 지속… 유전자 치료 및 단백질 약물 개발 지원]]>https://www.newswire.co.kr/newsRead.php?no=981166Fri, 15 Dec 2023 15:20:00 +0900<![CDATA[QPS Holdings, LLC Expands Operations in Springfield, Missouri]]>https://www.newswire.co.kr/newsRead.php?no=980227Tue, 05 Dec 2023 10:35:00 +0900<![CDATA[QPS 홀딩스, 미주리 스프링필드에서 사업 확장]]>https://www.newswire.co.kr/newsRead.php?no=980228Tue, 05 Dec 2023 10:35:00 +0900<![CDATA[QPS Holdings, LLC divests its Neuropharmacology Business Unit]]>https://www.newswire.co.kr/newsRead.php?no=980043Fri, 01 Dec 2023 13:10:00 +0900<![CDATA[QPS 홀딩스, 신경약리학 사업부 매각]]>https://www.newswire.co.kr/newsRead.php?no=980044Fri, 01 Dec 2023 13:10:00 +0900